Cough News and Research

RSS

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

An opinion article aims to provide evidence that SP could be the possible factor for initiating the cytokine storm during severe SARS-CoV-2 infection.

21 Sep 2021

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

A new study posted to the bioRxiv* server attempted to explore anti-spike IgG responses, Fc-gamma receptor (FcγR) activation, IgG targeting of immunodominant regions, and recall responses due to seasonal hCoV infections in non-hospitalized COVID-19 patients.

20 Sep 2021

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

A study evaluates the efficacy of a mAb to prevent disease progression in non-hospitalized persons with symptomatic SARS-CoV-2 infection.

17 Sep 2021

Pediatric SARS-CoV-2 infections usually mild, says study

A new study in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19.

16 Sep 2021

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

Months after Kyle Dixon died, his old house in Lanse, Pennsylvania, is full of reminders of a life cut short.

16 Sep 2021

NIH awards funding to build a national study population of volunteers on long-term effects of COVID-19

The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19.

15 Sep 2021

Over half of states have rolled back public health powers in pandemic

Republican legislators in more than half of U.S. states, spurred on by voters angry about lockdowns and mask mandates, are taking away the powers state and local officials use to protect the public against infectious diseases.

15 Sep 2021

Respiratory emissions during labor and delivery can increase the risk of disease transmission

Some medical procedures can put health care workers at higher risk for contracting COVID-19 and other respiratory diseases.

15 Sep 2021

Pregnancy complications with COVID-19

An important new article published in the Clinical Medicine Journal discusses pregnancy complicated with COVID-19.

14 Sep 2021

Metabolic and immune markers as tools for risk stratification and monitoring in COVID-19

In a new study posted to the medRxiv* server scientists from Weil Cornell University and Stony Brook University in New York attempted to identify the metabolic and immune markers associated with severe COVID-19 disease using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. This will facilitate risk stratification, monitoring, and therapeutic interventions in COVID-19 patients.

14 Sep 2021

An investigation of SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship

The Diamond Princess Cruise ship left Yokohama (Japan) on 20 January 2020, for a fourteen-day tour with shore excursions in Japan, Hong Kong, Vietnam, and Taiwan. Unfortunately, one of the passengers who complained of mild dry cough was later confirmed to be SARS-CoV-2 positive. In due course, 19% of the passengers were infected with the virus, and thirteen people died.

13 Sep 2021

Neuropsychiatric symptoms in children and adolescents with long COVID

In a recent study, researchers determine the presence of any neuropsychological symptoms after recovering from COVID-19 in children and adolescents.

8 Sep 2021

COVID-19 infection does not appear to affect the lung function of young adults, finds study

COVID-19 infection does not appear to affect the lung function of young adults, according to new research presented at the 'virtual' European Respiratory Society International Congress today (Tuesday).

7 Sep 2021

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

A new variant (lineage C.37) initially identified in Lima, Peru, has since been classified as “Lambda” by the World Health Organization (WHO). The lambda variant was classified in June 2021 by the WHO as a “variant of interest.”

6 Sep 2021

Your covid game plan: Are stadiums safe?

The college football season is kicking into high gear, the National Football League season starts Sept. 9, and the baseball pennant races are heating up. For the first time since 2019, nearly all stadiums will be fully open to fans.

3 Sep 2021

People who received two vaccine doses have lower odds of experiencing long COVID

People who tested positive for SARS-CoV-2 after one or two vaccine doses had significantly lower odds of severe disease or hospitalization than unvaccinated people, according to a large-scale study investigating COVID-19 breakthrough infections published in The Lancet Infectious Diseases journal.

2 Sep 2021

Double vaccination reduces the risk of Long COVID by almost half

Adults who have received a double vaccination are 49% less likely to have Long COVID should they contract a COVID-19 infection.

2 Sep 2021

New walk-through coronavirus testing facility opened in Bangor

A new walk-through coronavirus testing facility has opened for those with symptoms to book appointments at Beach Street Car Park West (LL57 1AT) in Bangor, as part of the UK Government's UK-wide drive to continue to improve the accessibility of coronavirus testing for local communities.

2 Sep 2021

Regional differences in prevalence of SARS-CoV-2 antibodies in children

A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.

2 Sep 2021

Researchers identify 55 lingering effects of COVID-19

As COVID-19 hospitalizations once again soar in a fourth surge more than 18 months after the pandemic started, some patients continue to experience symptoms long after recovering from COVID, according to a Houston Methodist study recently published in Nature's Scientific Reports.

30 Aug 2021

Cough News and Research

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

Pediatric SARS-CoV-2 infections usually mild, says study

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

NIH awards funding to build a national study population of volunteers on long-term effects of COVID-19

Over half of states have rolled back public health powers in pandemic

Respiratory emissions during labor and delivery can increase the risk of disease transmission

Pregnancy complications with COVID-19

Metabolic and immune markers as tools for risk stratification and monitoring in COVID-19

An investigation of SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship

Neuropsychiatric symptoms in children and adolescents with long COVID

COVID-19 infection does not appear to affect the lung function of young adults, finds study

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

Your covid game plan: Are stadiums safe?

People who received two vaccine doses have lower odds of experiencing long COVID

Double vaccination reduces the risk of Long COVID by almost half

New walk-through coronavirus testing facility opened in Bangor

Regional differences in prevalence of SARS-CoV-2 antibodies in children

Researchers identify 55 lingering effects of COVID-19

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News